Christina R. Lee

Biological Sciences Platform, Sunnybrook Research Institute

Affiliated withSunnybrook Research Institute

Research Area

Biography

Christina R. Lee has not added Biography.
If you are Christina R. Lee and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 23	2014

Other Publications

Article	Year
Friend virus-induced erythroleukemias: a unique and well-defined mouse model for the development of leukemia. Anticancer research\| PubMed ID: 12894591	2003
Low-dose metronomic combined with intermittent bolus-dose cyclophosphamide is an effective long-term chemotherapy treatment strategy. Cancer research\| PubMed ID: 16103050	2005
Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer using combination oral UFT-cyclophosphamide metronomic chemotherapy. Cancer research\| PubMed ID: 16585158	2006
On the origin and nature of elevated levels of circulating endothelial cells after treatment with a vascular disrupting agent. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 16921064	2006
Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. Science (New York, N.Y.)\| PubMed ID: 16990548	2006
Enhanced natural-killer cell and erythropoietic activities in VEGF-A-overexpressing mice delay F-MuLV-induced erythroleukemia. Blood\| PubMed ID: 17053052	2007
Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 17942672	2007
Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth. Cancer research\| PubMed ID: 18199548	2008
Long-term progression and therapeutic response of visceral metastatic disease non-invasively monitored in mouse urine using beta-human choriogonadotropin secreting tumor cell lines. Molecular cancer therapeutics\| PubMed ID: 18852148	2008
Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer cell\| PubMed ID: 19249681	2009
Dose-dependent increases in circulating TGF-alpha and other EGFR ligands act as pharmacodynamic markers for optimal biological dosing of cetuximab and are tumor independent. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 19276250	2009
Tumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapy. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 19671869	2009
Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1. Cancer research\| PubMed ID: 19738068	2009
Comparative impact of trastuzumab and cyclophosphamide on HER-2-positive human breast cancer xenografts. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 19825954	2009
Impact of metronomic UFT/cyclophosphamide chemotherapy and antiangiogenic drug assessed in a new preclinical model of locally advanced orthotopic hepatocellular carcinoma. Neoplasia (New York, N.Y.)\| PubMed ID: 20234820	2010
Differential post-surgical metastasis and survival in SCID, NOD-SCID and NOD-SCID-IL-2Rγ(null) mice with parental and subline variants of human breast cancer: implications for host defense m... PloS one\| PubMed ID: 23967178	2013
Preclinical recapitulation of antiangiogenic drug clinical efficacies using models of early or late stage breast cancer metastatis. Breast (Edinburgh, Scotland)\| PubMed ID: 24074794	2013